High levels of ELMO1-AS1 are associated with better treatment outcomes and may be an independent prognostic marker for HCC. Overexpression of ELMO1-AS1 can inhibit the proliferation, migration and invasion of HCC cells, and its target may be ELMO1. This evidence concerns the gene ELMO1 and hepatocellular carcinoma.